web logo
  • Therapies
    • DNX-2401
    • Combination Therapies
  • Diseases
    • Adult Brain Cancer
    • Pediatric Brain Cancer
  • Clinical Trials
    • Pediatric Clinical Trials
    • Adult Clinical Trials
    • Compassionate Use
  • Company
    • Management Team
    • Board of Directors
    • Key Advisors
    • Clinical Partners
  • Investor Resources
    • Company News & Presentations
    • Scientific Publications
    • Investor Presentations
  • Contact

Uncategorized

A Phase I Study of a Tropism-Modified Conditionally Replicative Adenovirus for Recurrent Malignant Gynecologic Diseases

Purpose: To determine the maximum tolerated dose (MTD), toxicity spectrum, clinical activity, and biological effects…

Read more

Phase I Trial of DNX-2401 for Diffuse Intrinsic Pontine Glioma Newly Diagnosed in Pediatric Patients

There are no effective treatments for diffuse intrinsic pontine gliomas (DIPGs); these tumors cannot be…

Read more

Oncolytic Virotherapy for Malignant Gliomas

The following represents disclosure information provided by authors of this manuscript. All relationships are considered…

Read more

DNX-2401 wins $2 million FDA grant for cancer immunotherapy

DNX-2401 has won a $2 million grant from the Food and Drug Administration to support…

Read more

Smart bomb virus shows promise as brain tumor immunotherapy

A common cold virus engineered to attack the most common and deadly of brain tumors…

Read more

DNX-2401 Demonstrates “Dramatic” Survival Benefit in Glioma

Treatment with the investigational agent DNX-2401 resulted in 20% of a cohort of patients with…

Read more

Re-engineered Cold Virus Increases Brain Cancer Patients’ Survival, Phase 1 Trial Shows

Re-engineering a common cold virus to attack the deadliest kind of brain tumor extended the…

Read more

Early Trial Shows ‘Smart Bomb’ Virus Extends Survival in Patients With Glioblastoma

Findings from an early phase clinical trial that used a so-called “smart bomb” virus —…

Read more

The Deadly Viruses Being Used To Combat Incurable Cancers

Zika, polio and adenovirus are hardly the first trio that comes to mind when considering…

Read more
  • <
  • 1
  • 2
  • 3
  • >
footer-logo
  • Address

    3400 Edloe Street, Suite 335 Houston, TX 77027

Therapies
  • DNX-2401 (tasadenoturev)
  • Combination Therapies
Diseases
  • Adult Brain Cancer
  • Pediatric Brain Cancer
Science
  • Pediatric Clinical Trials
  • Adult Clinical Trials
Company
  • Management Team
  • Board of Directors
  • Clinical Partners
Contact
  • Terms of Use Policy
  • Privacy Policy

Copyright © 2026. CVBio. All Rights Reserved